1.MDM2 amplification occurs in a subset of patients with atypical lipomatous tumor/well-differentiated liposarcoma, particularly in small biopsy samples.
2.MDM2 and CDK4 amplifications are frequently observed in both dedifferentiated liposarcoma and well-differentiated liposarcoma.
3.Dedifferentiated liposarcoma with epithelioid or epithelial-like morphology is easily misdiagnosed as carcinoma or mesothelioma, and MDM2 amplification plays a crucial role in differential diagnosis.
4.Similar to ALT/WDL, they exhibit ring chromosomes or giant marker chromosomes with amplification of the 12q13-21 region. Most retroperitoneal dedifferentiated liposarcomas show MDM2 amplification.
5.When diagnosing subcutaneous ALT/WDL, it is essential to first rule out lipomas with similar morphological features, such as spindle cell lipoma, pleomorphic lipoma, chondroid lipoma, and cellular angiolipoma. Additionally, differential diagnosis should include neurofibroma, well-differentiated sclerosing liposarcoma, and sometimes low-grade MPNST. The frequent co-amplification of MDM2 and CDK4 in ALT/WDL can aid in differential diagnosis.